摘要
槐果碱为喹诺里西啶类生物碱,是从豆科槐属植物苦参、山豆根等中草药中提取而来。研究表明,槐果碱在多种疾病的进展中能抑制TLR4-NF-κB/MAPK通路,减少各类炎症因子如IL-6、IL-1β、IL-8、TNF-α、PGE2和MCP-1等的释放,调节免疫细胞的分泌,抵抗炎症对机体的损害,进而发挥保护肝脏、改善心血管和抗自身免疫性疾病等多种药理作用。基于TLR4-NF-κB/MAPK-炎症轴对近年来槐果碱的多种药理作用作以综述,以期为槐果碱新药进一步研究提供参考。
Sophocarpine is a quinolizidine alkaloid,which is extracted from Chinese herbal medicines such as Sophora flavescens Ait and Sophorae Tonkinensis Radix et Rhizoma.Studies have shown that sophocarpine can inhibit TLR4-NF-B/MAPK pathway,reduce various inflammatory factors such as IL-6,IL-1β,IL-8,TNF-α,PGE2 and MCP-1,regulate the secretion of immune cells,resist the damage of inflammation to the body,and then play a variety of pharmacological effects,such as protecting liver,improving cardiovascular system and anti-autoimmune diseases.Therefore,based on the TLR4-NF-κB/MAPK-inflammatory axis,the various pharmacological effects of sophocarpine in recent years were reviewed,in order to provide reference for new drug development and clinical application.
作者
姜盛楠
张红
李晔
支文冰
宗时宇
刘洋
JIANG Shengnan;ZHANG Hong;LI Ye;ZHI Wenbing;ZONG Shiyu;LIU Yang(Shaanxi Academy of Traditional Chinese Medicine,Xi'an 710061,China)
出处
《现代中药研究与实践》
CAS
2023年第1期99-102,共4页
Research and Practice on Chinese Medicines
基金
陕西省重点研发计划(2022ZDXM-SF-06)
陕西省中医药管理局“秦药”开发重点科学研究项目(2021-02-ZZ-002,2021-02-GJ-021)
陕西省“秦药”研发重点实验室(2021-QYPT-001)
陕西中医药大学省级中医体质与疾病防治研究重点实验室(KF2209)。